Common use of Upon Approval Clause in Contracts

Upon Approval. Within ten (10) Business days of receipt by Auxilium, its Affiliate or Sublicensee of the first Regulatory Approval from the FDA for an Exercised Indication, Auxilium shall make the following milestone payments to BTC on a per Indication basis: Amount Labeling Approved for the following Indication $[**] [**] $[**] [**] $[**] [**] $[**] [**] $[**] [**] ** CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.

Appears in 3 contracts

Samples: Development and License Agreement (Auxilium Pharmaceuticals Inc), Development and License Agreement (Auxilium Pharmaceuticals Inc), Development and License Agreement (Auxilium Pharmaceuticals Inc)

AutoNDA by SimpleDocs

Upon Approval. Within ten (10) Business days of receipt by Auxilium, its Affiliate or Sublicensee Auxilium of the first Regulatory Approval from the FDA for an Exercised Indication, Auxilium shall make the following milestone payments to BTC on a per Indication basis: Amount Labeling Approved for the following Indication $[**] [**] $[**] [**] $[**] [**] $[**] [**] $[**] [**] ** CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.Each Additional Indication

Appears in 2 contracts

Samples: Development and License Agreement (Auxilium Pharmaceuticals Inc), Development and License Agreement (Auxilium Pharmaceuticals Inc)

AutoNDA by SimpleDocs

Upon Approval. Within ten (10) Business days of receipt by Auxilium, its Affiliate or Sublicensee of the first Regulatory Approval from the FDA for an Exercised Indication, Auxilium shall make the following milestone payments to BTC on a per Indication basis: Amount Labeling Approved for the following Indication $[***] [***] $[***] [***] $[***] [***] $[***] [***] $[***] [***] *** CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT REQUESTTREATMENT.

Appears in 1 contract

Samples: Development and License Agreement (Biospecifics Technologies Corp)

Time is Money Join Law Insider Premium to draft better contracts faster.